title: Pityriasis rubra pilaris successfully treated with infliximab.
authors.forename: Diana P
authors.initials: DP
authors.lastname: Ruiz-Genao
authors.forename: Jose Luis
authors.initials: JL
authors.lastname: Lopez-Estebaranz
authors.forename: Elena
authors.initials: E
authors.lastname: Naz-Villalba
authors.forename: Reyes
authors.initials: R
authors.lastname: Gamo-Villegas
authors.forename: Leticia
authors.initials: L
authors.lastname: Calzado-Villarreal
authors.forename: Fernando
authors.initials: F
authors.lastname: Pinedo-Moraleda
mesh_terms: D000911:Antibodies, Monoclonal / Q000627:therapeutic use*; D005260:Female; D006801:Humans; D007155:Immunologic Factors / Q000627:therapeutic use*; D000069285:Infliximab; D007262:Infusions, Intravenous; D008875:Middle Aged; D010916:Pityriasis Rubra Pilaris / Q000188:drug therapy* / Q000473:pathology; D012867:Skin / Q000473:pathology; D014409:Tumor Necrosis Factor-alpha / Q000037:antagonists & inhibitors
chemical_list: D000911:Antibodies, Monoclonal; D007155:Immunologic Factors; D014409:Tumor Necrosis Factor-alpha; D000069285:Infliximab